rachel cooney(@rachelcooney7) 's Twitter Profileg
rachel cooney

@rachelcooney7

Gastroenterologist and IBD specialist with research interest. Irish farmers daughter and taxi driver to teenage kids.

ID:2571511615

calendar_today16-06-2014 19:20:34

268 Tweets

355 Followers

521 Following

BSG(@BritSocGastro) 's Twitter Profile Photo

features a packed agenda including focussed sessions across all 4️⃣ days! Get your ticket today and don't forget to sign up to our exciting social events when you book πŸ’ƒ πŸ•Ί Looking forward to seeing you on 17th - 20th June in Birmingham πŸ‘‹ live.bsg.org.uk/register/

#BSGLIVE24 features a packed agenda including focussed #IBD sessions across all 4️⃣ days! Get your ticket today and don't forget to sign up to our exciting social events when you book πŸ’ƒ πŸ•Ί Looking forward to seeing you on 17th - 20th June in Birmingham πŸ‘‹ live.bsg.org.uk/register/
account_circle
Crohn's & Colitis UK(@CrohnsColitisUK) 's Twitter Profile Photo

A is a tunnel that connects one organ to another part of your body. Fistulas are a common complication of Crohn's, with around 1 in 3 people with Crohn’s developing a fistula. Fistulas can also happen in Colitis, but this is not as common πŸ‘‰ ow.ly/e3SC50Rm0GQ

A #fistula is a tunnel that connects one organ to another part of your body. Fistulas are a common complication of Crohn's, with around 1 in 3 people with Crohn’s developing a fistula. Fistulas can also happen in Colitis, but this is not as common πŸ‘‰ ow.ly/e3SC50Rm0GQ
account_circle
rachel cooney(@rachelcooney7) 's Twitter Profile Photo

Interested in IBD and getting the best patient outcomes after surgery ? Please join us and help deliver this important study.

account_circle
Seb(@ibdseb) 's Twitter Profile Photo

Delighted to see πŸ‡¬πŸ‡§ PANTS study 3 year extension data published in The Lancet Gastroenterology & Hepatology
πŸ™πŸΌ to the investigators and patients who participated
sciencedirect.com/science/articl…

⏺️Only 1/3 of those treated with TNFis remain in remission at 3years
⏺️Week 14 levels significant in reducing

Delighted to see πŸ‡¬πŸ‡§ PANTS study 3 year extension data published in @LancetGastroHep πŸ™πŸΌ to the investigators and patients who participated sciencedirect.com/science/articl… ⏺️Only 1/3 of those treated with TNFis remain in remission at 3years ⏺️Week 14 levels significant in reducing
account_circle
Ayman Bannaga(@AymanBannaga) 's Twitter Profile Photo

🌟 Exciting Opportunity Alert! 🌟

uhb.tal.net/vx/appcentre-e…

Are you a talented Gastro consultant looking to make a transformative impact in a supportive environment? Look no further than the Gastroenterology Unit at Queen Elizabeth Hospital Birmingham!

Here at QEHB, we offer a

🌟 Exciting Opportunity Alert! 🌟 uhb.tal.net/vx/appcentre-e… Are you a talented Gastro consultant looking to make a transformative impact in a supportive environment? Look no further than the Gastroenterology Unit at Queen Elizabeth Hospital Birmingham! Here at QEHB, we offer a
account_circle
Laura Targownik πŸ³οΈβ€βš§οΈπŸ‘©πŸΌβ€βš•οΈ(@laura_targownik) 's Twitter Profile Photo

Are we Excited about ETRASIMOD?

Or is it more Eh..trasimod??

Let's take a close look at the recently published paper evaluating the effectiveness of the Sphingosine-1-Phosphate Receptor Modulator ETRASIMOD in patients with ulcerative colitis

🧡🧡🧡

Are we Excited about ETRASIMOD? Or is it more Eh..trasimod?? Let's take a close look at the recently published paper evaluating the effectiveness of the Sphingosine-1-Phosphate Receptor Modulator ETRASIMOD in patients with ulcerative colitis 🧡🧡🧡
account_circle
Frontline Gastro(@FrontGastro_BMJ) 's Twitter Profile Photo

Check out latest study by Elford et al. on the real-world effectiveness of Upadacitinib in Crohn's disease. Their findings underscore Upa as a promising rx option for medically refractory CD

link: bit.ly/4aMZSvJ

Alex Elford, Nikolas Plevris, Nick Kennedy Mohsen Subhani

Check out latest study by Elford et al. on the real-world effectiveness of Upadacitinib in Crohn's disease. Their findings underscore Upa as a promising rx option for medically refractory CD link: bit.ly/4aMZSvJ @AlexElford3, @PlevrisN, @DrNickKennedy @MohsenSubhani
account_circle
Frontline Gastro(@FrontGastro_BMJ) 's Twitter Profile Photo

Don't miss the FG Editor's highlights from our latest issue, covering critical topics:
β€’FIT utilization
β€’IBD& hospital admissions
β€’Diet in CD & UC
β€’Nutrition training
β€’UGIB training

URL: bit.ly/4cSsWDC

Mark Beattie Mohsen Subhani Gio McGinty

account_circle
Crohn's & Colitis UK(@CrohnsColitisUK) 's Twitter Profile Photo

1 in 6 18-34 year olds are too embarrassed to talk to their GP about their symptoms, meaning their more likely to ignore key symptoms of Crohn’s and Colitis.
​
Β Don’t ignore your symptoms, use our symptom checker today.​
​
Visit: crohnsandcolitis.org.uk/Symptomchecker

account_circle
Anjan Dhar(@anjan_dhar6) 's Twitter Profile Photo

4 articles on Sustainability in one issue!! Thank you Frontline Gastroenterology for continuing to champion our cause to save the planet from the GHG effects of our professional practice. Essential reading for all. πŸ‘‡πŸ‘‡BSG Trainees BSG BSG Nursing Frontline Gastro

account_circle
rachel cooney(@rachelcooney7) 's Twitter Profile Photo

Well done Peter. Great to see this in print and hopefully it will help ensure earlier diagnosis and treatment for IBD patients

account_circle
BSG(@BritSocGastro) 's Twitter Profile Photo

Are you planning to join us at on 17th - 20th June at the ICC, Birmingham this year? πŸ“… Make sure you book your ticket by 5th April to get the best possible rate, we look forward to seeing you there! πŸ‘‹ live.bsg.org.uk/register/

Are you planning to join us at #BSGLIVE24 on 17th - 20th June at the ICC, Birmingham this year? πŸ“… Make sure you book your ticket by 5th April to get the best possible rate, we look forward to seeing you there! πŸ‘‹ live.bsg.org.uk/register/
account_circle